| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.405 | 39.535 | 38.809 | 38.058 | 50.395 | 60.443 | 57.448 | 59.638 | 59.908 |
| Total Income - EUR | - | 13.405 | 39.535 | 38.809 | 38.058 | 50.395 | 60.443 | 57.448 | 59.638 | 59.908 |
| Total Expenses - EUR | - | 1.377 | 10.308 | 12.114 | 14.151 | 16.224 | 17.645 | 28.813 | 27.839 | 33.012 |
| Gross Profit/Loss - EUR | - | 12.028 | 29.227 | 26.695 | 23.907 | 34.171 | 42.798 | 28.635 | 31.799 | 26.896 |
| Net Profit/Loss - EUR | - | 11.626 | 28.041 | 25.531 | 22.765 | 32.746 | 40.985 | 28.061 | 31.202 | 25.098 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Ted Perfusion Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 1.268 | 1.440 | 1.516 | 609 | 364 | 362 |
| Current Assets | - | 12.529 | 29.166 | 26.028 | 37.202 | 43.782 | 39.888 | 29.261 | 31.517 | 34.870 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 10.828 | 3.295 | 3.234 | 3.171 | 17.779 | 6.654 | 21.342 | 18.118 | 24.727 |
| Cash | - | 1.701 | 25.871 | 22.794 | 34.031 | 26.003 | 33.233 | 7.919 | 13.400 | 10.143 |
| Shareholders Funds | - | 11.671 | 28.094 | 25.582 | 22.816 | 32.795 | 41.033 | 28.109 | 31.251 | 25.147 |
| Social Capital | - | 45 | 44 | 43 | 0 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 858 | 1.072 | 445 | 16.725 | 13.415 | 1.413 | 2.779 | 1.767 | 10.282 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ted Perfusion Srl